Physician profile
Susan J Wright
NPI 1326120031
$580.36
in general payments reported to CMS, 2019-2025
19 companies · $86.16 in 2025
The $86.16 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $54.32 · 2021: $12.84 · 2022: $103 · 2023: $105 · 2024: $49.42 · 2025: $86.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $87.07 | 2022-2025 | Shingrix, Arexvy, Boostrix |
| Abbvie INC. | $76.75 | 2021-2023 | Vraylar |
| Amgen INC. | $73.87 | 2019-2025 | Otezla, Repatha |
| Novo Nordisk INC | $45.11 | 2019-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $34.55 | 2019-2025 | Farxiga |
| Sanofi-Aventis U.S. LLC | $29.88 | 2019 | |
| Philips North America LLC | $29.57 | 2022-2024 | (Cm9) Amb Mon & Diag Und |
| Lilly USA, LLC | $26.49 | 2022 | |
| Braemar Manufacturing, LLC | $22.10 | 2019 | |
| Novocure INC. | $19.43 | 2023 | Optune |
| Novartis Pharmaceuticals Corporation | $18.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.85 | 2020 | |
| Abbott Laboratories | $16.87 | 2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $16.09 | 2019 | |
| Sanofi Pasteur INC. | $15.64 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $14.30 | 2025 | Voquezna |
| Exact Sciences Corporation | $13.34 | 2023 | Cologuard Collection Kit |
| Eisai INC. | $11.98 | 2020 | |
| Merck Sharp & Dohme LLC | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.